A controversial “birth control” drug, approved by the Food and Drug Administration (FDA) despite evidence that it induces abortion in women who take it, is now on sale in the U.S. On December 1 Watson Pharmaceuticals, the New Jersey-based distributor of the drug known as “Ella,” announced that it is now available by prescription at pharmacies and clinics across the nation, as well as through some online pharmacies.
You win some; you lose some. In October, a federal judge in Michigan dismissed a lawsuit challenging ObamaCare’s individual mandate, arguing that Congress has the power to impose such a mandate under the Commerce Clause. A week later a federal judge in Florida permitted a similar lawsuit to proceed because he believed that the individual mandate stretched the Commerce Clause beyond the breaking point, saying that for him it “is not even a close call.” A Virginia federal judge had previously permitted another lawsuit to proceed on similar grounds.
When the American people learned that the congressmen who wrote the new healthcare law were exempt from it, questions regarding the alleged benefits of the new legislation were raised. Further proof that ObamaCare may not be all that it was touted to be can be found in the fact that 111 companies, including a number of unions, have been given waivers to be exempted from certain provisions of the law.